Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures

Pathology Research and Practice

Volumn 208, Issue 3, 2012, Pages 140-146

  Tsuneki, Masayuki ^a   Maruyama, Satoshi ^b   Yamazaki, Manabu ^a   Cheng, Jun ^a   Saku, Takashi ^a,b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Cell proliferation; Extracellular matrix; Immunohistochemistry; Odontogenic tumors; Podoplanin

Indexed keywords

BETA1 INTEGRIN; CYCLINE; FIBRONECTIN; GELATINASE B; PODOPLANIN;

AMELOBLASTOMA; ARTICLE; BASAL CELL; CANCER CELL; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; INTERCELLULAR SPACE; ODONTOGENIC CYST; ODONTOGENIC KERATOCYST; ODONTOGENIC TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SPINDLE CELL; TISSUE SPECIFICITY;

EXTRACELLULAR MATRIX; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; MEMBRANE GLYCOPROTEINS; ODONTOGENIC TUMORS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84863406957     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.12.016     Document Type: Article

References (40)

1. Alvarado C.G., Maruyama S., Cheng J., Ida-Yonemochi H., Kobayashi T., Yamazaki M., Takagi R., Saku T. Nuclear translocation of β-catenin synchronized with loss of E-cadherin in oral epithelial dysplasia with a characteristic two-phase appearance. Histopathology 2011, 59:283-291.
2. Breiteneder-Geleff S., Matsui K., Soleiman A., Meraner P., Poczewski H., Kalt R., Schaffner G., Kerjaschki D. Podoplanin novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 1997, 151:1141-1152.
3. Cheng J., Irié T., Munakata R., Kimura S., Nakamura H., He R.G., Liu A.R., Saku T. Biosynthesis of basement membrane molecules by salivary adenoid cystic carcinoma cells: an immunofluorescence and confocal microscopic study. Virchows Arch. 1995, 426:577-586.
4. Daugaard S., Christensen L.H., Hogdall E. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2 cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40. APMIS 2009, 117:518-525.
5. Dumoff K.L., Chu C., Xu X., Pasha T., Zhang P.J., Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod. Pathol. 2005, 18:97-104.
6. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005, 46:396-402.
7. Funayama A., Cheng J., Maruyama S., Yamazaki M., Kobayashi T., Syafriadi M., Kundu S., Shingaki S., Saito C., Saku T. Enhanced expression of podoplanin in oral carcinoma in situ and squamous cell carcinomas. Pathobiology 2011, 78:171-180.
8. Gockel I., Domeyer M., Sgourakis G.G., Schimanski C.C., Moehler M., Kirkpatrick C.J., Lang H., Junginger T.H., Hansen T. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J. Surg. Oncol. 2009, 100:191-198.
9. González-Alva P., Inoue H., Miyazaki Y., Tsuchiya H., Noguchi Y., Kikuchi K., Ide F., Ishihara S., Katayama T., Sakashita H., Kusama K. Podoplanin expression in odontomas: clinicopathological study and immunohistichemical analysis of 86 cases. J. Oral Sci. 2011, 53:67-75.
10. González-Alva P., Tanaka A., Oku Y., Miyazaki Y., Okamoto E., Fujinami M., Yoshida N., Kikuchi K., Ide F., Sakashita H., Kusama K. Enhanced expression of podoplanin in ameloblastomas. J. Oral Pathol. Med. 2010, 39:103-109.
11. Ida-Yonemochi H., Ahsan M.S., Saku T. Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signaling pathways for cellular growth and differentiation. Histopathology 2011, 58:234-245.
12. Ida-Yonemochi H., Ikarashi T., Nagata M., Hoshina H., Takagi R., Saku T. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch. 2002, 441:165-173.
13. Ida-Yonemochi H., Nakajima M., Saku T. Heparanase, heparan sulfate and perlecan distribution along with the vascular penetration during stellate reticulum retraction in the mouse enamel organ. Arch. Oral Biol. 2010, 55:778-787.
14. Ida-Yonemochi H., Ohshiro K., Swelam W., Metwaly H., Saku T., Perlecan a basement membrane-type heparan sulfate proteoglycan in the enamel organ: its intraepithelial localization in the stellate reticulum. J. Histochem. Cytochem. 2005, 53:763-772.
15. Ikarashi T., Ida-Yonemochi H., Ohshiro K., Cheng J., Saku T. Intraepithelial expression of perlecan a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium. J. Oral Pathol. Med. 2004, 33:87-95.
16. Imaizumi Y., Amano I., Tsuruga E., Kojima H., Sawa Y. Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs. Acta Histochem. Cytochem. 2010, 43:115-121.
17. Ishii M., Ota M., Saito S., Kinugasa Y., Akamoto S., Ito I. Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int. J. Colorectal Dis. 2009, 24:1069-1074.
18. Kawaguchi H., El-Naggar A.K., Papadimitrakopoulou V., Ren H., Fan Y.H., Feng L., Lee J.J., Kim E., Hong W.K., Lippman S.M., Mao L. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J. Clin. Oncol. 2008, 26:354-360.
19. Kimura S., Cheng J., Toyoshima K., Oda K., Saku T. Basement membrane heparan sulfate proteoglycan (perlecan) synthesized by ACC3 adenoid cystic carcinoma cells of human salivary gland origin. J. Biochem. 1999, 125:406-413.
20. Kobayashi T., Maruyama S., Cheng J., Ida-Yonemochi H., Yagi M., Takagi R., Saku T. Histopathological varieties of oral carcinoma in situ: diagnosis aided by immunohistochemistry dealing with the second basal cell layer as the proliferating center of oral mucosal epithelia. Pathol. Int. 2010, 60:156-166.
21. Kundu S., Cheng J., Maruyama S., Suzuki M., Kawashima H., Saku T. Lymphatic involvement in the histopathogenesis of mucous retention cyst. Pathol. Res. Pract. 2007, 203:89-97.
22. Kunita A., Kashima T.G., Morishita Y., Fukayama M., Kato Y., Tsuruo T., Fujita N. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis. Am. J. Pathol. 2007, 170:1337-1347.
23. Martin-Villar E., Megias D., Castel S., Yurrita M.M., Vilaro S., Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell Sci. 2006, 119:4541-4553.
24. Mishima K., Kato Y., Kaneko M.K., Nishikawa R., Hirose T., Matsutani M. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol. 2006, 111:483-488.
25. Miyakuni Y., Matsumoto T., Arakawa A., Sonoue H., Suzuki C., Takeda S. Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus. Pathol. Int. 2008, 58:471-476.
26. Murata M., Cheng J., Horino K., Hara K., Shimokawa H., Saku T. Enamel proteins and extracellular matrix molecules are co-localized in the pseudocystic stromal space of adenomatoid odontogenic tumor. J. Oral Pathol. Med. 2000, 29:483-490.
27. Okamoto E., Kikuchi K., Miyazaki Y., González-Alva P., Oku Y., Tanaka A., Yoshida N., Fujinami M., Ide F., Sakashita H., Kusama K. Significance of podoplanin expression in keratocystic odontogenic tumor. J. Oral Pathol. Med. 2010, 39:110-114.
28. Ordonez N.G. D2-40 podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum. Pathol. 2005, 36:372-380.
29. Sawa Y., Iwasawa K., Ishikawa H. Expression of podoplanin in the mouse tooth germ and apical bud cells. Acta Histochem. Cytochem. 2008, 41:121-126.
30. Shimada Y., Ishii G., Nagai K., Atsumi N., Fujii S., Yamada A., Yamane Y., Hishida T., Nishimura M., Yoshida J., Ikeda N., Ochiai A. Expression of podoplanin CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci. 2009, 100:2054-2059.
31. Shimizu Y., Jin L., Yamaguchi H., Motosugi U., Sannohe S., Nagata K., Sakurai T., Murata S., Yasuda M., Shimizu M. Detection of lymphatic invasion in resected cases of primary pancreatic cancer based on immunohistochemistry of D2-40. Ann. Diagn. Pathol. 2009, 13:168-172.
32. Suzuki-Inoue K., Fuller G.L., Garcia A., Eble J.A., Pohlmann S., Inoue O., Gartner T.K., Hughan S.C., Pearce A.C., Laing G.D., Theakston R.D., Schweighoffer E., Zitzmann N., Morita T., Tybulewicz V.L., Ozaki Y., Watson S.P. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006, 107:542-549.
33. Suzuki-Inoue K., Kato Y., Inoue O., Kaneko M.K., Mishima K., Yatomi Y., Yamazaki Y., Narimatsu H., Ozaki Y. Involvement of the snake toxin receptor CLEC-2 in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 2007, 282:25993-26001.
34. Tsuneki M., Cheng J., Maruyama S., Ida-Yonemochi H., Nakajima M., Saku T. Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor. J. Oral Pathol. Med. 2008, 37:287-293.
35. Tsuneki M., Yamazaki M., Cheng J., Maruyama S., Kobayashi T., Saku T. Combined immunohistochemistry for the differential diagnosis of cystic jaw lesions: its practical use in surgical pathology. Histopathology 2010, 57:806-813.
36. Wicki A., Lehembre F., Wick N., Hantusch B., Kerjaschki D., Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006, 9:261-272.
37. Yang S., Zhu X., Cai L., Cheng H., Zhao R., Wang H., Zhao H., Wang Z. Role of tumor-associated lymphatic endothelial cells in metastasis: a study of epithelial ovarian tumor in vitro. Cancer Sci. 2010, 101:679-685.
38. Yu H., Pinkus G.S., Hornick J.L. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms. Am. J. Clin. Pathol. 2007, 128:767-775.
39. Yuan P., Temam S., El-Naggar A., Zhou X., Liu D.D., Lee J.J., Mao L. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006, 107:563-569.
40. Zustin J., Scheuer H.A., Friedrich R.E. Podoplanin expression in human tooth germ tissues and cystic odontogenic lesions: an immunohistochemical study. J. Oral Pathol. Med. 2010, 39:115-120.